With apologies to the late Yankees slugger Yogi Berra, for pandemic-weary Americans, it’s like “déjà vu all over again,” as new lockdowns and mandatory mask mandates are being imposed across the globe. The latest threat, the Omicron C…
Category: Meds
How drug distributors contributed to the opioid crisis
A recent headline in my neighborhood newspaper read, “A Dentist Became a Top Opioid Buyer in W. Va. Now a Drug Firm Faces Penalty for Ignoring Red Flags.” The drug firm sent 25,400 hydrocodone pills and 3,600 Xanax to one Huntington, WV are…
COVID-19 monoclonal antibodies are a bridge to vaccination
Attention-grabbing headlines suggest that our crucial COVID-19 pandemic tools—monoclonal antibodies and vaccines—are incompatible. Beyond the controversy rests an evidence-based reality: monoclonal antibodies and vaccines are complementary aspects of p…
Is Descovy really the better option?
When the FDA approved Gilead’s Truvada (emtricitabine/tenofovir disoproxil) for HIV PrEP in 2012, it was a revolutionary step forward. The drug was safe and up to 99 percent effective in preventing HIV infection in at-risk individuals. Then in 20…
How did we let insurers run health care?
How did we Americans allow health insurers to dictate how physicians practice good medicine? The hypocritic oath says, “Do no harm.” We should not allow insurance company profits to prevent proper care for patients. Our insurer is now telli…
The people vs. opioid pharma: Pharma wins again
On Monday, November 1, an Orange County California Superior Court Judge said, in a tentative decision, that the opioid pharmaceutical companies were not responsible for the opioid crisis. This particular case, going by the name of “The People of the St…
The rise of targeted therapies: the era of the patient-focused approach
There is an urgent need for innovation in cancer treatments. Although we’ve seen significant progress in indications for drugs treating particular diseases, cancer research data shows that 10-year survival statistics for cancers such as esophageal and …
Ivermectin is a Nobel Prize-winning wonder drug
Ivermectin is an over 30-year-old wonder drug that treats life- and sight-threatening parasitic infections. Its lasting influence on global health has been so profound that two of the key researchers in its discovery and development won the Nobel Prize…
Questions about pharma pricing and marketing
In 2017, Allergan CEO Brent Saunders promised to reign in drug price hikes, and other Pharma companies followed suit. In 2021, it looks like all bets are off. In August, Amgen raised the price of its psoriasis med Otezla by 2.4 percent after raising th…
The abundant and colorful world of pharmaceuticals
Creative photography Year after year, new medications find their way into the market, adding to the abundant and colorful world of pharmaceuticals. Medications play a dual role in our lives, as they represent wellness and illness concomitantly. I am pr…
